Globe Life (NYSE:GL) CEO Sells $9,121,500.00 in Stock

Globe Life Inc. (NYSE:GL - Get Free Report) CEO James Matthew Darden sold 50,000 shares of the stock in a transaction that occurred on Friday, July 31st. The shares were sold at an average price of $182.43, for a total transaction of $9,121,500.00. Following the completion of the sale, the chief executive officer owned 58,451 shares in the company, valued at $10,663,215.93. This represents a 46.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Globe Life Trading Up 1.2%

Shares of GL opened at $184.37 on Tuesday. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07. Globe Life Inc. has a 1-year low of $127.85 and a 1-year high of $191.55. The stock has a market cap of $14.31 billion, a price-to-earnings ratio of 12.24 and a beta of 0.48. The firm has a 50 day simple moving average of $172.08 and a 200-day simple moving average of $154.64.




Globe Life (NYSE:GL - Get Free Report) last posted its earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $3.67 by ($0.06). The company had revenue of $1.60 billion during the quarter, compared to analysts' expectations of $1.59 billion. Globe Life had a net margin of 19.58% and a return on equity of 20.73%. Globe Life's quarterly revenue was up 8.0% compared to the same quarter last year. During the same period in the previous year, the company posted $3.05 EPS. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Equities analysts forecast that Globe Life Inc. will post 15.7 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on GL shares. Piper Sandler increased their price objective on Globe Life from $175.00 to $200.00 and gave the company an "overweight" rating in a research note on Wednesday, July 15th. JPMorgan Chase & Co. upped their target price on shares of Globe Life from $181.00 to $201.00 and gave the company an "overweight" rating in a report on Tuesday, July 21st. Jefferies Financial Group raised their price target on shares of Globe Life from $147.00 to $166.00 and gave the stock a "hold" rating in a research note on Friday, July 10th. Keefe, Bruyette & Woods lowered their price target on shares of Globe Life from $192.00 to $190.00 and set an "outperform" rating for the company in a report on Friday, July 24th. Finally, TD Cowen boosted their price objective on shares of Globe Life from $215.00 to $225.00 and gave the company a "buy" rating in a research report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $191.67.

Check Out Our Latest Analysis on Globe Life

Hedge Funds Weigh In On Globe Life

Large investors have recently bought and sold shares of the stock. Compound Planning Inc. raised its holdings in Globe Life by 4.3% during the 4th quarter. Compound Planning Inc. now owns 1,968 shares of the company's stock worth $275,000 after purchasing an additional 82 shares during the last quarter. Root Financial Partners LLC boosted its stake in shares of Globe Life by 23.3% in the 1st quarter. Root Financial Partners LLC now owns 439 shares of the company's stock valued at $61,000 after purchasing an additional 83 shares during the last quarter. Transcend Capital Advisors LLC grew its position in shares of Globe Life by 3.9% during the 4th quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company's stock worth $317,000 after buying an additional 84 shares during the period. Natural Investments LLC grew its position in shares of Globe Life by 2.6% during the 4th quarter. Natural Investments LLC now owns 3,452 shares of the company's stock worth $482,000 after buying an additional 87 shares during the period. Finally, Parallel Advisors LLC raised its stake in shares of Globe Life by 5.6% during the fourth quarter. Parallel Advisors LLC now owns 1,651 shares of the company's stock worth $231,000 after buying an additional 87 shares during the last quarter. Hedge funds and other institutional investors own 81.61% of the company's stock.

Globe Life Company Profile

(Get Free Report)

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

Featured Articles

Insider Buying and Selling by Quarter for Globe Life (NYSE:GL)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Globe Life?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Globe Life and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles